Company page

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (ticker: LCTX) is a public company based in the United States, focused on developing innovative cell therapies. With a market capitalization of approximately $256.8 million, Lineage is dedicated to advancing treatments for various medical conditions through its proprietary technologies. The company aims to improve patient outcomes by leveraging its expertise in regenerative medicine.